Eplivanserin

id: eplivanserin-180-480518
title: Eplivanserin
text: Eplivanserin was an experimental drug for the treatment of insomnia which was being developed by Sanofi Aventis. Sanofi Aventis announced in December 2009 that it was withdrawing its application for approval of eplivanserin from both the U.S. Food and Drug Administration and the European Medicines Agency.
brand slug: wiki
category slug: encyclopedia
description: Chemical compound
original url: https://en.wikipedia.org/wiki/Eplivanserin
date created: 2009-03-30T13:00:32Z
date modified: 2024-09-05T12:18:40Z
main entity: {"identifier":"Q5383774","url":"https://www.wikidata.org/entity/Q5383774"}
image: {"content_url":"https://upload.wikimedia.org/wikipedia/commons/d/d6/Eplivanserin_structure.svg","width":512,"height":200}
fields total: 13
integrity: 16

Related Entries

Explore Next Part